Wexham Park Hospital Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2004
NCT00125996
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2004

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

sucroferric oxyhydroxide (velphoro) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia, Iron-Deficiency (Phase 2)

Heart Diseases (Phase 2)

Heart Failure (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1